Express Scripts (ESRX) Aims to Clamp Down on High Drug Prices; Excludes Valeant's (VRX) Glumetza from Formulary
Tweet Send to a Friend
Express Scripts (Nasdaq: ESRX) moved to drop Valeant's (NYSE: VRX) Glumetza from its formulary today, according to CNBC's David Faber.The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
